Algosource   Report issue

For profit
Founded: Saint-Nazaire France (2008)

Organization Overview

First Clinical Trial
2016
NCT02817620
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Algosource

Active Ingredients

Drugs in Other Trials (1)

spirulina (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1